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Porcine reproductive and respiratory syndrome virus (PRRSV) is a member of the positive-strand RNA virus family
Arteriviridae. Although considerable research has focused on this important pathogen, little is known about the function of
most PRRSV proteins. To examine characteristics of putative nonstructural proteins (nsp) encoded in ORF1b, which have
been identified by nucleotide similarity to domains of equine arteritis virus, defined genomic regions were cloned and
expressed in the pRSET expression system. One region, nsp10, encoded a protein with a putative helicase domain and was
further examined for functional helicase-like activities. PRRSV nsp10 was found to possess a thermolabile and pH-sensitive
NTPase activity that was modulated by polynucleotides and to unwind dsRNA in a 5 to 3 polarity. These results provide the
first evidence of the functional properties of PRRSV helicase and further support the finding that nidovirus helicases possessINTRODUCTION
Porcine reproductive and respiratory syndrome virus
(PRRSV) emerged in the late 1980s and became a patho-
gen of scientific interest due to its economic importance.
Analysis of PRRSV structure, genomic organization, and
expression and its biological, physicochemical, and
pathogenic properties has shown that PRRSV is related
to equine arteritis virus (EAV), lactate dehydrogenase-
elevating virus of mice (LDV), and simian hemorrhagic
fever virus (SHFV) (Benfield et al., 1992; Collins et al.,
1992; Meulenberg et al., 1993; Plagemann and Moennig,
1992). These viruses are grouped in a new family desig-
nated Arteriviridae and placed with the Coronaviridae
family within the order Nidovirales (Cavanagh, 1997).
PRRSV has been revealed to consist of two distantly
related genotypes, North American (NA, 15.4 kb) and
European (EU, 15.1 kb), based on sequence analysis
(Allende et al., 1999; Meulenberg et al., 1993; Murtaugh
et al., 1995, 1998; Nelsen et al., 1999). The genome of
PRRSV encodes at least eight open reading frames
(ORFs) that are expressed in the infected cell as a nested
set of subgenomic mRNAs. ORF1, translated from the
full-length RNA template, codes for replicase-related
nonstructural proteins and is the focus of this study.
ORFs 2 to 7 encode mostly structural polypeptides.
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258ORF1 contains two long open reading frames, desig-
nated ORF1a and ORF1b, that are autocatalytically pro-
cessed by virally encoded proteases (Meulenberg et al.,
1993). ORF1b is only expressed by ribosomal 1 frame
shifting due to a slippery sequence and pseudoknot
structure in the overlapping ORF1a/ORF1b junction (Al-
lende et al., 1999; den Boon et al., 1991; Brierly et al.,
1989; Meulenberg et al., 1993; Nelsen et al., 1999; Woot-
ton et al., 2000). The catalytic domains and cleavage
sites for EAV ORF1 have been identified. The EAV pro-
teases, located within nsp1, nsp2, and nsp4, have been
shown to cleave EAV ORF1ab into 12 nonstructural pro-
teins (nsps), 8 in ORF1a and 4 in ORF1b (den Boon et al.,
1995; Snijder et al., 1992, 1993a,b; Snijder and Meulen-
berg, 1998; van Dinten et al., 1996, 1999; Wassenaar et
al., 1997). EAV nsp1 autocatalytically cleaves the ORF1
protein immediately downstream between G260 and
G261; nsp2 is proposed to cleave far downstream be-
tween two glycine residues located at EAV amino acids
1367 and 1368, and nsp4, the major protease, cleaves
ORF1 between amino acids glutamine and glycine (EG)
or glutamine and serine (ES) (Ziebuhr et al., 2000). Based
on significant homology in the catalytic domains and in
predicted cleavage sites, it was surmised that PRRSV
polymerase may undergo similar proteolytic processing
as that of EAV (Snijder and Meulenberg, 1998; van Dinten
et al., 1999; Wassenaar et al., 1997; Ziebuhr et al., 2000).
The four predicted ORF1b nonstructural polypeptides
comprise a putative RNA-dependent RNA polymeraseproperties that distinguish them from other viral helicases
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(POL or nsp9), a protein (nsp10) containing a putative
metal-binding domain (MBD) and nucleoside triphos-. © 200
RNA-d
phate binding or helicase motif (HEL), and two proteins
of unknown function (nsp 11 and 12). Nsp11 contains a
domain (CORONA) that is conserved in all nidoviruses
(Allende et al., 1999, 2000; den Boon et al., 1991; Godeny
et al., 1993; Gorbalenya et al., 1989; Herold et al., 1996;
Meulenberg et al., 1993; Nelsen et al., 1999; Shen et al.,
2000; Snijder and Meulenberg, 1998; van Dinten et al.,
1996, 1999; Wootton et al., 2000).
Despite extensive research on the molecular and bi-
ological properties of PRRSV, there are important as-
pects of the disease and biology that remain unclear.
The role of the nonstructural genes encoded in ORF1ab
in viral replication, pathogenesis, and immunity have not
been demonstrated. This information is necessary to
devise effective strategies to prevent and control PRRSV
infection of swine. The knowledge available for the
genes encoded in ORF1ab is limited to sequence infor-
mation for a few virus isolates (Allende et al., 1999, 2000;
Jiang et al., 2000; Meulenberg et al., 1993; Nelsen et al.,
1999; Shen et al., 2000; Wootton et al., 2000) and predic-
tions on their function based on sequence homology and
studies on EAV and coronaviruses (Gorbalenya et al.,
1989; Herold et al., 1996; Snijder and Meulenberg, 1998;
van Dinten et al., 1999). To elucidate the role of the
nonstructural genes of arteriviruses in virus replication,
previous studies have been done with EAV (12.7 kb) to
develop and characterize infectious clones and their
derivative mutants (de Vries et al., 2000; van Dinten et al.,
1997, 2000; van Marle, 1999). These studies have pro-
vided important insights as to the critical role of the
genes encoded in ORF1ab in arterivirus replication.
However, PRRSV is genetically divergent from EAV, pos-
sessing only approximately 41% (ORF1a) to 48% (ORF1b)
nucleotide identities to the sequenced EAV cell-adapted
avirulent strain (Nelsen et al., 1999). In addition, infec-
tious clones of PRRSV have been more difficult to pre-
pare and analyze, apparently due to the increased
genomic size of PRRSV (15.1–15.4 kb), the restricted cell
tropism of this virus, and the difficulty in transforming
these permissive cells with nucleic acids (Meulenberg et
al., 1998). We have chosen a virulent field isolate of
PRRSV to explore phenotypic properties of this virus as it
exists in nature. To demonstrate and characterize PRRSV
ORF1b polypeptides, we have generated recombinant
individual nsp proteins that were then analyzed under
controlled conditions. This article describes the first
functional studies of the putative PRRSV helicase.
RESULTS
Cloning and expression of PRRSV ORF1b
polypeptides
Two overlapping ORF1b gene segments were ampli-
fied by RT-PCR and designated CF and IH. These gene
segments were cloned and confirmed to be PRRSV-14-
specific nucleotides by sequence analysis. The nucleo-
tide sequence of PRRSV-14 ORF1b has been deposited
in GenBank (Accession No. AF298771). Nucleotide se-
quence comparison of PRRSV-14 ORF1b revealed that
this isolate is closely related to PRRSV-NA strains (data
not shown). Sequence analysis also determined that the
predicted cleavage sites for PRRSV ORF1b were main-
tained in isolate PRRSV-14 (Allende et al., 1999; Nelsen et
al., 1999). These predicted cleavage sites appear to be
well conserved among PRRSV strains (Table 1).
Genome clones CF and IH both contained an overlap-
ping unique SacI site that was used to generate a
5262-nt CH fragment, which comprised all ORF1b
flanked by minimal ORF1a sequence at the 5 end and by
a small amount of ORF2 sequence at the 3 end. The CH
fragment was cloned and used as a template to generate
PCR-amplified ORF1b nsp gene fragments (Fig. 1A).
These gene fragments were cloned into pRSET-B plas-
mids for protein expression and designated pTPRRSV14
nsp9–12. Western blot analysis with T7.10 Ab demon-
strated that the produced recombinant proteins corre-
sponded to polypeptides of the predicted molecular size
(Fig. 1B). To confirm the specificity of the individual nsps,
antipeptide rabbit sera were generated as described
under Materials and Methods. Western blot analyses
with nsp10 antipeptide rabbit sera (-HEL, Fig. 1B) or
other gene-specific anti-peptide sera (data not shown)
demonstrated the specificity of PRRSV-14-specific indi-
vidual nsps.
Experiments were conducted to obtain soluble recom-
binant PRRSV-14 ORF1b proteins. Optimal conditions for
nsp10, which is predicted to have RNA helicase and
ATPase functions (Meulenberg et al., 1993), were ob-
tained with the Escherichia coli strain BL21(DE3)pLysE,
which has been designed to have more stringent expres-
TABLE 1
Predicted Cleavage Sites for PRRSV ORF1b Protein
Cleavage site PRRSV isolates Amino acid sequence






Note. ORF1b amino acid alignment of North American and European
isolates (GenBank Accession Nos. are indicated in the text) was per-
formed using the Pileup program of SeqWeb Version 1.2 of the Wiscon-
sin Package Version 10.1. The predicted cleavage sites are underlined
and based on sequence homology to the predicted sites described for
EAV (Meulenberg et al., 1993; Nelsen et al., 1999; van Dinten et al., 1996,
1999). Lowercase indicates amino acid difference at that position
compared to the reference NA strain.
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sion of the T7 polymerase. In addition, culturing of trans-
formed bacteria at 22°C and the use of reduced-nutrient
media further improved expression. Under these condi-
tions and after 3 h of IPTG induction, approximately
60–80% of expressed recombinant nsp10 protein was
soluble.
Efforts were directed to obtain purified nsp10 and to
characterize its predicted NTPase function and demon-
strate its helicase activity. To obtain purified recombinant
PRRSV-14 helicase, proteins in soluble extracts from bac-
teria transformed with pTPRRSV14-nsp10 were adsorbed
by affinity to cobalt or nickel resins and eluted as de-
scribed. Samples obtained in the last elution fractions
from nickel columns provided a highly purified helicase-
soluble protein preparation (95% pure based on Coo-
massie blue staining, Fig. 2). Protein preparations ob-
tained with cobalt resins also yielded adequate yields
but had reduced ATPase activity compared to nickel
affinity-purified protein (data not shown). Therefore,
nickel affinity-purified nsp10 helicase was used for the
characterization of its inherent ATPase and helicase ac-
tivities. With similar conditions, soluble nsp11 and nsp12
were obtained (data not shown) and used as controls in
the subsequent experiments as indicated.
NTPase activity of recombinant PRRSV-14 helicase
As initial proof of helicase-like activity, experiments
were performed to test the ability of purified PRRSV-14
nsp10 protein to hydrolyze radiolabeled ribonucleotides
in the presence or absence of polyribonucleotides. From
the autoradiographic films of the chromatographs (Fig.
3), it was apparent that PRRSV nsp10 helicase hydro-
lyzed all four nucleotides in the absence of polynucleo-
tides. Polynucleotides did not appear to significantly af-
fect the level of nucleotide hydrolysis, except for a slight
reduction in the level of hydrolysis of CTP in the pres-
ence of poly(U). To further characterize the NTPase func-
tion of PRRSV nsp10 helicase, the subsequent studies
were performed with ATP as substrate.
FIG. 2. Metal-affinity purification of PRRSV-14 helicase. Elution frac-
tions (E) containing the recombinant PRRSV-14 ORF1b nsp10 or heli-
case polypeptide were subjected to SDS–PAGE and Coomassie blue
staining. Elution fractions 3 to 9 and 10 to 12 were pooled and dialyzed.
The dialyzed protein samples are indicated by D. Molecular markers
(MM) are indicated at the left in kDa. The T7.10 control protein (C) was
also included.
FIG. 1. Cloning and expression of PRRSV-14 ORF1b nonstructural
proteins (nsp). (A) Schematic representation of the strategy for cloning
and expressing PRRSV ORF1b nsps. Genome organization of PRRSV
with the ORF1b region shown expanded below. Motifs identified by
sequence comparison are indicated. Nsp9, 10, 11, and 12 gene seg-
ments are indicated by arrows. The letters on the open bars indicate
the primers used for amplification and the numbers in italics represent
the predicted molecular size of the amplified products. The IH- and
CF-amplified gene segments were selected for cloning and sequenc-
ing. The cloned IH and CF gene fragments were consequently ligated
at the SacI restriction site to generate the CH fragment (represented by
the cross-hatched bar) that contains the complete ORF1b gene of
PRRSV-14. The recombinant polypeptides from PRRSV-14 ORF1b that
were expressed in the prokaryotic system are presented by lines. The
number in italics on the lines represent the predicted molecular size in
kilodaltons (kDa) of PRRSV-14 ORF1b polypeptide fragments. The his-
tidine (His)-T7.10 tag derived from the expression vector increased the
molecular size in approximately 3.6 kDa. (B) Western blot analysis of
the expressed recombinant proteins with the indicated antibodies
described in the text. Molecular markers (MM) are indicated by the
numbers at the left in kDa. A positive control protein for the monoclonal
antibody T7.10 was included (T7C). As negative control, bacterial
extracts that were transformed with empty plasmids (pRSET) were
included to test each antibody. The protein bands that were specifically
recognized by the antibodies and had the expected molecular size of
the predicted polypeptide are indicated by arrows.
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Characterization of recombinant nsp10 helicase
ATPase activity
The level of ATPase activity in recombinant PRRSV
helicase was compared to the ATPase activity in control
samples. The control samples were obtained following
the same procedure used for purification of recombinant
helicase and consisted of protein preparations (equal-
ized by protein concentration) obtained from bacteria
transformed with one of the following plasmids: (1) empty
pRSET, (2) pTprrsvnsp11, or (3) pTprrsvnsp12. The results
demonstrated that the hydrolysis of ATP appeared spe-
cific for recombinant nsp10 (PRRSV helicase) and not for
possible contaminating bacterial proteins. These results
also established that both predicted nsp11 and predicted
nsp12 products lacked a specific ATPase activity (Fig. 4).
The ATPase activity of PRRSV helicase was shown to
be dependent on recombinant protein concentration (Fig.
4). PRRSV helicase ATPase activity was also determined
to be dependent on pH (optimal pH range was between
7.5 and 8.5) and influenced by the assay buffer used (Fig.
5A). With Tris buffer, the ATPase activity of PRRSV heli-
case was stable over a broader pH range than with the
other buffers tested (Fig. 5A). There was no significant
differences seen in the level of ATPase activity using Tris
buffer concentrations in the range of 10 to 100 mM (data
not shown). Further characterization of the ATPase activ-
ity was performed using 25 mM Tris buffer at pH 8.0.
PRRSV helicase activity was dependent on the presence
of divalent ions, as the presence of EDTA inhibited the
recombinant proteins’ ATPase activity in a dose-depen-
dent manner (Fig. 5B). In addition, there was no ATPase
activity observed in the absence of divalent ions (Fig.
5C). Optimal ATPase activity was detected at 1–2 mM for
all the four divalent ions tested. Whereas the level of
ATPase activity of PRRSV helicase consistently remained
stable over a broader range of MgCl2 concentrations,
increasing concentrations of MnSO4 inhibited the activity
in a dose-dependent manner and to a greater extent than
the other divalent ions tested (Fig. 5C). Lastly, the ATPase
activity of PRRSV helicase was very sensitive to temper-
ature. Optimal activity was detected between 25 and
30°C. The ATPase activity was significantly reduced at
37.5°C and was only detected at background levels at
temperatures at and above 40°C and completely abol-
ished at 60°C (Fig. 5D). Kinetic analysis of recombinant
helicase ATPase activity revealed dependence on time
(Fig. 6A) and substrate concentration (Fig. 6B). The
Michaelis–Menten constant (KM) for the ATPase activity
of PRRSV helicase was determined to lie in the range of
6–13 mM ATP, with a maximum velocity of 1.3–2 mM ATP
hydrolyzed per min (Fig. 6C).
To assess whether the level of ATPase activity would
be affected by the presence of polynucleotides, kinetic
analysis was performed in the presence or absence of
poly(U). Poly(U) significantly enhanced the ATPase activ-
ity of PRRSV helicase at a given ATP level (Fig. 7A).
Although maximum velocity of enzymatic activity was not
reached, comparison of the initial velocities of the rela-
tive ATPase activities showed that the presence of
poly(U) increased the KM and Vmax at least 19- and 24-
fold, respectively. However, at low ATP concentrations,
poly(U) did not have an effect or tended to reduce the
ATPase activity (Table 2). The fold increase in the level of
ATP hydrolyzed induced by poly(U) was in a close linear
proportion (r 2  0.9817) to the concentration of ATP
substrate (Fig. 7B). These data indicate that the effect of
polynucleotides on the ATPase activity of PRRSV is de-
pendent on ATP substrate concentration. This result also
explains our initial findings (Fig. 4), in which no apparent
effect of the polynucleotides was detected when the ATP
concentration was limited and the level of ATPase activ-
ity present in the assay was nearly 100% of the substrate.
Last, the effect of the presence of other mononucle-
otides on the level of ATPase activity was ascertained
using the bioluminescence detection method (McElroy
and DeLuca, 1983). This assay has been shown to spe-
FIG. 4. Specificity of the ATPase activity of PRRSV-14 helicase. The
specificity of the ATPase activity was determined by testing the indi-
cated protein concentrations of purified recombinant proteins prepared
as described in the text. The ATPase assay was performed using 0.1
M of ATP substrate and the level of ATP remaining in the samples was
measured after 30 min incubation. The level of ATPase activity is
expressed as the percentage of ATP hydrolyzed in the ATPase assay.
Data represent the mean  standard deviation of triplicate samples.
FIG. 3. PRRSV putative helicase has NTPase activity in the absence
of polynucleotides. The NTPase assay was performed as described
under Materials and Methods with 0.01 Ci/l of the radiolabeled
nucleotides ATP, CTP, GTP, or UTP in the presence () or absence ()
of 0.1 g/l poly(U) or poly(A) and 0 () or 5 ng/l () of protein (HEL).
The migration of the triphosphate nucleotide substrates and diphos-
phate nucleotide products are indicated at the left.
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cifically detect ATP (Moyer and Henderson, 1983). In
addition, we confirmed that the measurement of ATP by
the bioluminescence method was not affected by the
presence of CTP, GTP, or UTP (data not shown). As
shown in Fig. 8, CTP, GTP, and UTP inhibited the level of
ATP hydrolysis by PRRSV helicase only when they were
present at concentrations at least 10-fold higher than the
ATP substrate. This result confirms that PRRSV nsp10
helicase protein can interact with all four nucleotides
and, furthermore, this helicase protein may have a higher
affinity for ATP than for the other nucleotides.
Unwinding properties of PRRSV helicase
To demonstrate whether recombinant PRRSV helicase
possessed functional RNA unwinding activity, various
substrates were designed and tested in a standard he-
licase assay. These substrates consisted of two partially
complementary RNA strands containing single-stranded
(ss) regions at the 3 or 5 ends of one or both strands.
One set of substrates designed to contain single-strand
regions at both 3 and 5 ends did not initially form the
expected partial duplex structures under initial hybridiza-
tion conditions. One explanation is that these long oligo-
nucleotides are predicted to form secondary structures
(energies of 25 to 30 kcal/mol; data not shown) and
therefore might not have initially annealed to the other
strand. However, duplexes or other higher ordered struc-
tures appear to form in the presence of recombinant
helicase (data not shown). One suggestion for this result
is that PRRSV helicase first promoted unwinding of initial
interoligonucleotide structures, then winding to form the
expected duplexes, and/or introducing secondary struc-
tures in the labeled RNA strand.
To further analyze the predicted helicase activity of the
PRRSV nsp10 protein, experiments were performed us-
ing duplex substrates prepared with synthetic oligonu-
cleotides containing single-strand regions at the 3 or 5
ends and short duplex regions (21 and 24 bp). Results
obtained with RNA 3Duplex and 33Duplex indicated
that PRRSV helicase lacked 3-to-5 unwinding activity
(Fig. 9A). In contrast, results with the RNA 5Duplex
revealed that PRRSV helicase has unwinding activity in
the 5-to-3 orientation (Fig. 9B). The 5-to-3 orientation
of the unwinding activity of the PRRSV helicase was
FIG. 5. Characterization of the ATPase activity of PRRSV helicase. (A) Effect of pH on the ATPase activity. (B) Effect of various concentrations (in
mM) of EDTA on the ATPase activity of PRRSV helicase (HEL) when tested in the presence of 3 mM MgCl2 as determined by TLC. (C) Requirement
and concentration effect of divalent ions on the ATPase activity. (D) Effect of temperature on the ATPase activity. The percentage (%) of the ATPase
activity is expressed as the percentage of the total ATP substrate that was hydrolyzed in the assay. Data in A, C, and D represent the mean standard
error of triplicate samples tested under the same experimental conditions. The concentration of ATP substrate used in these assays was 0.1 M. At
this substrate concentration, 5 ng/l of the highly purified PRRSV helicase hydrolyzed nearly 100% of the ATP substrate under optimal conditions after
30 min incubation.
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further confirmed in experiments using substrates pre-
pared with in vitro transcribed RNA that contained single-
strand regions at the 5 end of both strands and duplex
regions of 67 bp (55Duplex #1) and 85 bp (55Duplex
#2), as shown in Fig. 9B. These results, together with the
ATPase data described above, demonstrate that the re-
combinant PRRSV nsp10 helicase is functionally active
and shares the properties reported for helicases of other
members of the Nidovirales (Seybert et al., 2000a,b).
DISCUSSION
The nonstructural polypeptides encoded in Nidovi-
rales ORF1b regions have been predicted to have essen-
tial roles in virus replication and gene expression (Al-
lende et al., 1999; Gorbalenya et al., 1989; Meulenberg et
al., 1993; Nelsen et al., 1999; van Dinten et al., 1996).
Evidence for the significant role of these proteins in
arteriviruses has been derived using an infectious clone
of EAV (van Dinten et al., 1997, 1999, 2000; van Marle et
al., 1999). However, as stated previously, EAV is geneti-
cally distinct from other arteriviruses, possessing only
approximately 48% nucleotide identity and 53.8% amino
acid identity in the ORF1b region when compared to
PRRSV-NA (Nelsen et al., 1999). Thus, it is crucial to
gather basic information on distantly related arterivi-
ruses to examine variability in ORF1b nucleotide compo-
sition and function and to assess outcomes of potential
ORF1b region mutations. This study was completed to
provide molecular tools to facilitate understanding of the
biochemical and functional properties of PRRSV-NA-pre-
dicted ORF1b-processed polypeptides.
Accordingly, we have cloned and expressed predicted
ORF1b protein products of PRRSV-14 in a prokaryotic
system and determined optimal conditions for functional
expression of soluble nsp10, nsp11, and nsp12. Of these
three polypeptides, nsp10 was chosen for further bio-
chemical characterization, as this predicted protein has
been shown by sequence comparison to contain con-
served NTPase and helicase domains (Allende et al.,
1999; Nelsen et al., 1999; Meulenberg et al., 1993) of the
superfamily (SF) 1 of helicases (Kadare and Haenni,
1997; Seybert et al., 2000a,b).
PRRSV-NA nsp10 bears only approximately 45% amino
acid similarity to nsp10 of EAV (Nelsen et al., 1999),
illustrating remarkable interfamily divergence and ren-
dering possible differences in precise dynamics for this
critical protein. The described studies demonstrated that
the predicted nsp10 product containing the metal binding
and NTPase-helicase domains of PRRSV ORF1b has
NTPase activity. The initial NTPase analysis, determined
by thin-layer chromatography, revealed that PRRSV heli-
case hydrolyzes the four ribonucleotides in the absence
of polynucleotides. The interaction of the recombinant
FIG. 7. Effect of poly(U) on the kinetics of the ATPase activity of
PRRSV helicase. (A) Nonlinear regression analysis of the initial velocity
of the ATPase activity of PRRSV helicase in the presence () or
absence () of poly(U). The velocity (V) is expressed as the M
concentration of ATP hydrolyzed per min. (B) Linear regression analysis
of the poly(U)-induced fold increase in the ATPase activity (total M
ATP hydrolyzed in the assay) of PRRSV helicase as a function of the
concentration of ATP substrate.
FIG. 6. Kinetics analysis of the ATPase activity of PRRSV helicase. (A)
ATPase activity of PRRSV helicase tested with radiolabeled ATP as
substrate at various incubation times. (B) Kinetics analysis of the
ATPase activity of PRRSV helicase at various ATP substrate concentra-
tions for the indicated incubation times as determined with the biolu-
minescence ATP assay. (C) Nonlinear regression analysis (R 2 
0.9962) of the initial velocity of the ATPase activity of PRRSV helicase.
The substrate and product concentrations are expressed in M. The
velocity of the ATPase activity is expressed as the M product (ATP
hydrolyzed) per min. Data represent the mean  standard error of
triplicate separate samples. The Lineweaver–Burk plot of ATP hydroly-
sis is shown in the inserted graph in C.
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PRRSV helicase with the nucleotides was confirmed by
demonstrating that the presence of excess GTP, CTP,
and UTP inhibited the level of ATP hydrolysis. The ability
of PRRSV helicase to catalyze hydrolysis of different
nucleotides is a characteristic shared by various re-
ported viral helicases (Bisaillon et al., 1997; Kadare et al.,
1996; Li et al., 1999; Preugschat et al., 1996; Rikkonen et
al., 1994). We demonstrated that the activity observed for
the recombinant his-tagged nsp 10 is specific for the
helicase because the recombinant PRRSV ORF1b nsp11
and nsp12 polypeptides that were expressed and puri-
fied under the same conditions as PRRSV helicase did
not have specific ATPase activity. Although ATPase ac-
tivity has been previously reported for the human coro-
navirus 229E helicase (Heussip et al., 1997; Seybert et
al., 2000a), a member of the order Nidovirales, and more
recently for EAV (Seybert et al., 2000b), this is the first
study reporting the characterization of the NTPase activ-
ity of the putative helicase of PRRSV.
The characterization of the ATPase activity revealed
some features of PRRSV helicase that are common
among known viral helicases such as the requirement
for divalent cations and sensitivity to extreme pH and
temperatures. In contrast to other viral helicases (Bisail-
lon et al., 1997), PRRSV helicase appears to be extremely
sensitive to temperatures above physiological levels.
This finding suggests that viral or cellular factors may
be required to stabilize PRRSV helicase function. The
ATPase activity of PRRSV helicase was also dependent
FIG. 8. Effect of CTP, GTP, and UTP on the ATPase activity of PRRSV
helicase. The ATPase assay was performed with 0.1 M ATP substrate
in the presence of the indicated concentrations (in M) of CTP, GTP, or
UTP as described in the text. The level of ATP hydrolysis was deter-
mined after 30 min incubation by the bioluminescence ATP detection
method. Data are expressed as the mean of the percentage inhibition
of ATPase activity determined from three separate samples. Error bars
indicate the standard deviation of the mean.
FIG. 9. PRRSV helicase activities. RNA substrates were generated by
annealing two partially complementary RNA strands for use in a stan-
dard helicase (hel) assay. RNA substrate predicted duplex structures
are indicated by diagrams above each assay result. A sample lacking
PRRSV helicase (H) was included to indicate migration of intact
radiolabeled duplex, and denatured substrates (H, 95°C) were in-
cluded to indicate migration of unduplexed labeled short strand. Mi-
gration of substrates after the helicase assay is indicated on each
electropherogram as single-stranded (ss) or double-stranded (ds) oli-
gomers. (A) Results of the helicase assay with substrates containing 3
single regions at one (3Duplex) or both (33Duplex) strands and
duplex regions of 21 and 24 bp, respectively. (B) PRRSV helicase activity
displaced the labeled short strand of 5 tailed RNA substrates with
duplex lengths of 21 (5Duplex), 67 (5,5Duplex-#1), and 85 bp (55Du-
plex-#2).
TABLE 2
The Effect of Poly(U) on the ATPase Activity of PRRSV Helicase
Is Dependent on the Concentration of ATP Substrate
Substrate
(M ATP)
Mean M ATP hydrolyzed
Fold
effect P *Poly(U) Poly(U)
0.30 0.27 (0.01) 0.18 (0.01) 0.67 0.01
0.75 0.59 (0.02) 0.42 (0.04) 0.71 0.08
1.50 1.10 (0.02) 0.87 (0.02) 0.79 0.03
3.00 1.70 (0.02) 1.79 (0.02) 1.05 0.03
5.00 2.47 (0.18) 2.84 (0.11) 1.15 0.14
7.00 2.84 (0.21) 3.55 (0.19) 1.25 0.17
10.00 3.66 (0.17) 4.73 (0.05) 1.29 0.04
13.00 4.13 (0.34) 5.92 (0.21) 1.43 0.08
15.00 4.71 (0.15) 7.87 (0.06) 1.67 0.01
17.00 4.85 (0.34) 8.50 (0.42) 1.75 0.02
20.00 5.06 (0.24) 9.66 (0.39) 1.91 0.02
26.00 5.45 (0.48) 12.80 (0.85) 2.35 0.03
38.00 6.03 (0.43) 20.59 (1.68) 3.41 0.01
50.00 6.23 (0.42) 25.55 (1.39) 4.10 0.01
75.00 7.40 (1.25) 33.75 (1.76) 4.56 0.01
100.00 6.18 (0.90) 40.29 (2.24) 6.52 0.01
Note. The ATPase assay was performed as described under Mate-
rials and Methods at the indicated ATP concentrations in the presence
() or absence () of poly(U) in triplicate.
* Statistical significance was determined by paired two-sample t-test
with alpha at 0.05.
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on protein concentration. Although the presence of
polynucleotides was not required for detecting the
NTPase activity of PRRSV helicase using the standard
TLC method, poly(U) had a significant effect on this
activity when the activity was measured at various ATP
substrate concentrations. Interestingly, the effect of
poly(U) in the ATPase activity of PRRSV helicase was
dependent on the substrate concentration. At ATP con-
centrations lower than the estimated KM, poly(U) had an
inhibitory effect, whereas at higher ATP concentrations,
poly(U) had a stimulatory effect on the ATPase activity of
PRRSV helicase. It was also interesting to note that the
level of effect of poly(U) was in a close linear relationship
with the ATP substrate concentration.
The substrate concentration-dependent modulatory
effect of polynucleotides on the ATPase activity of PRRSV
helicase found in this study has not been previously
described. Data reported for other viral helicases are
consistent with a stimulatory effect that varies depending
on the type of helicase and polynucleotide used
(Rikkonen et al., 1994; Tamura et al., 1993). The level of
nucleic acid stimulation reported for the known members
of the viral SF1 and SF3 helicases has only been in the
range of a twofold increase, whereas higher levels of
stimulation have been reported for SF2 helicases (Ka-
dare and Haenni, 1997). The ATPase activity of the hu-
man coronavirus 229E, which belongs to the same
Nidovirales order as PRRSV, was found to be highly
stimulated with polynucleotides and the major stimula-
tory effect was found with poly(U), which increased the
NTPase activity of the helicase up to 50-fold (Heusipp et
al., 1997; Seybert et al., 2000a). A 20-fold increase in the
ATPase activity by polynucleotides was found for the EAV
helicase (Seybert et al., 2000b). For PRRSV helicase we
found that whereas the overall effect of poly(U) on the KM
and Vmax reached levels of 19- and 24-fold increase,
respectively, the effect on the amount of ATP hydrolyzed
varied from 0.6-fold (at 0.3 M ATP substrate) to 6.5-
fold (at 100 M ATP substrate). Experimental data ana-
lyzing the effect of polynucleotides under the range of
ATP substrate concentrations used in this study have not
been reported for other viral helicases. Therefore, it is
not clear whether our findings represent a unique feature
of PRRSV helicase. We suggest that the modulatory ef-
fect of poly(U) on the ATPase activity of PRRSV helicase
discovered in this study may have biological relevance
regarding virus replication and gene expression. It is
tempting to speculate that if PRRSV helicase is involved
in the processes of its genome replication and transcrip-
tion, as suggested by the studies with the mutant EAV
infectious clones (van Dinten et al., 1997, 2000; van Marle
et al., 1999), PRRSV helicase needs to be regulated to
achieve a balance between nucleotide hydrolysis and
viral RNA synthesis. Analysis of the crystal structure of
PRRSV helicase will be important to determine whether
the regulatory effect of polynucleotides in the ATPase
activity of PRRSV helicase is dependent on conforma-
tional changes differentially induced by various ratios of
ATP substrate to polynucleotide bound to the protein.
To further characterize PRRSV helicase function in
terms of its major predicted role in RNA winding, studies
analyzing the ability of the protein to interact with various
substrates were performed. The recombinant helicase
did not exhibit 3 to 5 unwinding activity on synthesized
oligomer duplexes of 22 or 24 bp and single-strand
regions of 15–16 nucleotides. The PRRSV helicase did
demonstrate 5-to-3 unwinding activity on duplexed sub-
strates with single-stranded segments on one or both 5
ends. These results are consistent with the 5-to-3 un-
winding properties found for EAV (Seybert et al., 2000b)
and HCoV (Seybert et al., 2000a), supporting the finding
that Nidovirales SF1 helicases are closely related with
functional properties different to those of other viral he-
licase families.
This study provides the first evidence on both ATPase
and helicase-like activities of PRRSV helicase and sug-
gests a regulatory role of polynucleotides on its ATPase
activity and unwinding properties. The molecular tools
developed in this study will be useful for further studies
directed to understand the role of the predicted interme-
diate ORF1b gene protein products in PRRSV replication.
MATERIALS AND METHODS
Virus selection, purification, and RNA isolation
A PRRSV isolate, designated PRRSV-14, was obtained
from the National Veterinary Services Laboratories
(NVSL, Ames, IA). Selection of isolate PRRSV-14 was
based on its clinical history and its ability to replicate
well in the MARC-145 cell line (Kim et al., 1993). The virus
was isolated from the serum of an 8-day-old piglet ex-
hibiting interstitial pneumonia. The piglet had come from
an Alabama farm experiencing a reproductive disease
outbreak in March of 1996. PRRSV-14 was propagated in
MARC-145 cells to passage level 9–10. Culture fluid con-
taining virions was concentrated by ultracentrifugation
through a 0.5-M sucrose cushion and further purified by
sucrose gradient centrifugation as described (Bautista et
al., 1996). Viral RNA was extracted from the purified virus
with Trizol reagent (GIBCO-BRL), concentrated by alcohol
precipitation, suspended in RNase-free double distilled
water, and stored at 70°C until analyzed.
RT-PCR, cloning, and sequencing analysis of
PRRSV-14 ORF1b genomic segments
PRRSV-14 gene fragments containing ORF1b se-
quences were amplified by RT-PCR. Reverse transcrip-
tion was performed in a 100-l reaction containing 1 g
of purified viral RNA, 0.25 g random hexamers, and
1000 U Superscript II reverse transcriptase (GIBCO-BRL),
following the manufacturer’s recommendations. Polymer-
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ase chain reactions (PCR) were performed in 50 l re-
actions using 2 l viral cDNA, 200 M dNTPs, 1 U
high-fidelity Vent (New England Biolabs), and various set
of primers (Table 3) according to the strategy depicted in
Fig. 1A. The reactions were performed by an initial de-
naturation for 5 min at 94°C, followed by 30 cycles and 10
min final extension at 72°C. The cycles consisted of
denaturation at 95°C for 45 s, annealing at 58°C for 1
min, and extension at 73°C for 2.10 min 10 s/cycle. The
extension time for gene products longer than 3000 nt
was performed for 3.2 min 10 s/cycle. Two overlapping
fragments, designated CF and IH (Fig. 1A), were cloned
into the pCRBlunt Vector system (Invitrogen). Plasmid
DNA from selected CF and IH clones were purified using
a plasmid purification kit (Qiagen) according to the man-
ufacturer’s instructions and confirmed by enzymatic re-
striction and sequence analysis. Sequence analysis was
performed with plasmid-specific primers at the auto-
mated sequence facility at Eli Lilly and Co., Indianapolis,
IN. PRRSV sequences used for nucleotide and amino
acid comparison included published GenBank se-
quences U87392 (VR-2332; Nelsen et al., 1999),
AF066183 (RespPRRS; Yuan et al., 2001), AF066384
(PrimePac; Yuan et al., 1999), AF184212 (SP, Shen et al.,
2000), AF176348 (PA8, Wootton et al., 2000), and
M96262.1 (Lelystad; Meulenberg et al., 1993).
Cloned CF and IH fragments were joined at a unique
SacI restriction site to generate a 5262-nt CH fragment
(Fig. 1A), which comprised the last 182 nt of ORF1a, all of
ORF1b, and the first 711 nt of ORF2. Four CH clones
(CH2, CH11, CH18, and CH37) were confirmed for proper
frame and orientation by restriction digest and sequence
analysis. The CH2 clone was used as a template for
further ORF1b nsp gene subcloning. Gene fragments
encoding predicted ORF1b nsps (nsp 9 to 12) were am-
plified by PCR and cloned into the pCRBlunt vector using
PRRSV-14-specific primers (Table 3) designed to contain
restriction sites for cloning into the prokaryotic pRSET-B
expression vector (Invitrogen). pRSET-B bacterial expres-
sion vector cloning was performed following standard
techniques (Sambrook, 1989). Briefly, the gene fragments
were inserted into the BamHI and KpnI sites of the
pRSET. The recombinant pRSET plasmids containing
ORF1b nsp genes were confirmed for proper orientation
and frame by enzymatic restriction analysis and by se-
quencing the region at the insertion sites. The recombi-
nant plasmids were designated pT-prrsvnspN, where N
corresponded to the number of the cloned ORF1b nsp.
Expression analysis of predicted ORF1b nsp,
optimization of protein expression,
and protein purification
The pRSET vector system allows the expression of
recombinant proteins via transcription by IPTG-induced
T7 polymerase. ORF1b nsps were expressed as recom-
binant proteins attached at their amino-terminus to a tag
containing a polyhistidine peptide, the antigenic peptide
T7.10, and an enterokinase cleavage site. Ten to fifty
nanograms of recombinant pRSET-B plasmid DNA con-
taining the corresponding ORF1b fragments were placed
in E. coli BL21(DE3)pLysS- or BL21(DE3)pLysE-compe-
tent cells by bacterial transformation following the man-
ufacturer’s recommendations (Invitrogen). Expression of
soluble recombinant proteins was optimized by culturing
transformed bacterial clones at various temperatures, in
TABLE 3
Primers Used for Cloning PRRSV-14 ORF1b Genes
Name Sequence














a Primers were designed based on published nucleotide sequences from PRRSV isolates VR  ATCC-VR-2332 (26) and NE  16244B (1).
b Primers were designed based on PRRSV-14-specific sequences.
c F  forward primer; R  reverse primer.
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different culture media, and by varying IPTG-induction
times. Recombinant protein expression was confirmed
by Western blot analysis of crude protein extracts with a
chemiluminescence detection kit (Boehringer Mann-
heim) using selected antibodies, including a monoclonal
antibody to the polyhistidine peptide (Clontech), a T7.10
tag antibody (Novagen), and peptide-specific polyclonal
antisera generated to PRRSV-14 nsp 9, 10, and 11 (de-
scribed below). After optimal conditions were deter-
mined, soluble recombinant proteins were purified from
bacterial extracts by affinity to cobalt (Novagen) or Ni-
NTA (Qiagen) resins according the manufacturer’s rec-
ommendations. Recombinant proteins were eluted with
300 mM imidazole. Eluted fractions were subjected to
electrophoresis, followed by Coomassie blue staining,
and Western blot analysis. Fractions containing the pu-
rified recombinant protein of interest were pooled and
dialyzed against 50 mM Tris pH 7.5 containing 1% glyc-
erol and 1 mM DTT. Purified proteins were stored at
20°C until further analysis. Purified recombinant pro-
tein concentrations were determined by colorimetric as-
say (Smith et al., 1985) using the BCA Protein Assay
Reagent Kit (Pierce) with bovine serum albumin (BSA) as
standard.
Antipeptide sera
Antigenic regions for development of antipeptide sera
were selected by computer analysis of peptide hydro-
phobicity/antigenicity indices of the predicted amino acid
sequences of PRRSV-14 nsp 9, 10, and 11 genes. The
amino acid sequences of the peptides used to generate
the antibodies were (C)HRPSTYPAKNSMAGINGRFPTKD
for nsp9, (C)EQGLTPLDPGRYQTRRG for nsp10, and
(C)REYLDDRERE for nsp11. Peptide synthesis, KHL con-
jugation, polyclonal rabbit antibody production, and af-
finity purification of antibodies were contracted with
Zymed Laboratories, Inc. Affinity-purified antibodies were
preadsorbed with lysates of porcine alveolar macro-
phages, MARC-145, and E. coli cells at 4°C overnight,
clarified by centrifugation, filtered through a 0.22-nm fil-
ter, and aliquots stored at 20°C. Optimal antibody con-
centration was determined by testing serial dilutions of
antibodies by Western blot of crude protein extracts.
Analysis and characterization of NTPase activity of
PRRSV-14 nsp10 (helicase)
The functionality of the recombinant nsp10 helicase
was initially determined by assessing NTPase activity on
standard thin layer-chromatography (Gwack et al., 1999).
Purified protein samples were incubated with 0.1 Ci of
-32P-labeled ribonucleotide in 10 l of a solution con-
taining 2 mM DTT, 1 mM NaCl, and 100 g/ml BSA at
different conditions. The samples were analyzed under
various divalent ion concentrations, temperatures, time
periods, protein concentrations, pH conditions, and
buffer systems. The divalent ions tested included MgCl2,
MgSO4, MnCl2, and MnSO4. Different pH conditions were
tested using buffers containing 25 mM MES, 25 mM
PIPES, 25 mM HEPES, or 25 mM Tris. Reaction products
(2 l) were spotted onto polyethylenimine (PEI)-cellulose
F plates (EM Science). Chromatographs were developed
in 0.4 M KH2PO4 (pH 3.5), dried, autoradiographed, and
analyzed by densitometry or phosphoimaging.
The ATP bioluminescence assay kit CLS II (Boehringer
Mannheim) was used for quantitative analysis of nsp 10
ATPase activity. In this assay, the bioluminescent signal
emitted by the oxidation of luciferin is directly propor-
tional to the ATP concentration present in the test sample
(McElroy and DeLuca, 1983). This assay was performed
in triplicate at conditions described above (10-l reac-
tions) with 0.1 to 1 M ATP (Promega) as substrate. For
kinetic analysis, the level of ATP hydrolysis produced by
the recombinant nsp 10 helicase was measured at dif-
ferent concentrations of ATP and at various incubation
times. After incubation, the helicase was inactivated at
90°C for 5 min and samples were diluted with 19 vol of
50 mM Tris–HCl pH 8.0 buffer containing 2 mM EDTA.
Diluted samples (50 l) were transferred in triplicate to
Microfluor B 96-well flat-bottom plates (Dynex Technolo-
gies Inc.). The bioluminescence signal of samples and
standards was measured with an Anthos Lucy Micro-
plate Luminometer and Photometer (Labtech Interna-
tional, Ringmer, U.K.). The ATP concentration in the test
samples was determined based on a standard curve
obtained by the ATP bioluminescence kit manufacturer’s
instructions (Boehringer Mannheim). The ATPase activity
of PRRSV nsp10 in each experimental condition was
expressed as the percentage of ATP hydrolyzed calcu-
lated by
	





where [ATP test]  concentration of the test samples
ATP in the presence of the recombinant; and [ATP con-
trol]  concentration of ATP in parallel samples in the
absence of the recombinant proteins. Kinetics of the
ATPase activity was determined by measuring the con-
centration of ATP hydrolyzed per min of reaction time.
This assay was performed using 100 nM protein in 10 l
reaction buffer containing 25 mM Tris pH 8.0, 3 mM
MgCl2, 100 g/ml BSA, 1 mM NaCl, 2 mM DTT with
various concentrations of ATP at 35°C for 5 min. The
5-min incubation was selected because it was within the
range at which the rate of ATP hydrolysis was linear (Fig.
7B). The KM of PRRSV-14 helicase ATPase activity was
determined by nonlinear regression analysis of the
Michaelis–Menten equation using the Prism program
version 3.0 (GraphPad Software) according to the
method described by Motulsky (1999).
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Preparation of helicase substrates and helicase
assay
Duplexed RNA substrates were prepared using both syn-





GCCGCCGTCGACTT-3 (SS2-3), and 5-ACTAGTGGTT-
TCACCTAGAATGGCTGCGTCCCTTCTTTTCCTC-3 (LS2-3)
were purchased from Annovis (Aston, PA). The SS1 and
SS2-3 were labeled at the 5 end with [-32P]-ATP (Amer-
sham, 3000 Ci/mmol) using T4 polynucleotide kinase and
purified using the QIAquick Nucleotide removal kit (QIA-
GEN). Duplexes were generated by annealing the labeled
short strands with 10-fold excess unlabeled long strands as
described (Seybert et al., 2000b). The following substrates
were obtained by annealing RNA oligos for 10 min at 95°C:
5 Duplex (SS1  LS-5), 3Duplex (SS1  LS-3), 33Du-
plex (SS2-3  LS2-3).
In vitro transcribed RNA was generated using plas-
mids pGEM-L and pGEM-S as templates. DNA frag-
ments were generated by RT-PCR amplification of
strain VR-2332 3-untranslated region from a previ-
ously prepared clone (pTVRsgORF7; unpublished




CATGCGGC) to generate 5-TTAATTGGCGAGAACCAT-
GCGGCCGAAATTAACAAAAAAAAAAAAAAAAAAAGCG-
GCCGCGAATTCCGGAATCACTAGTGCCA-3 (L fragment) and
5-TTAACAAAAAAAAAAAAAAAAAAAGCGGCCGCGAATT-
CCGGAATCACTAGTGCCA-3 (S fragment). After ApaI and
NdeI digestion, these fragments were cloned into the respec-
tive sites of pGEM-T to produce two plasmids (pGEM-S and
pGEM-L). These plasmids were subsequently digested with
either ApaI (SP6 orientation), SacI (T7 orientation), or NsiI (T7
orientation), purified using the QIAquick PCR purification kit
(QIAGEN), and blunt-ended prior to in vitro transcription. In
vitro transcription was performed with SP6 and T7 poly-
merases using RiboMAXLarge Scale RNAProduction System
(Promega). pGEM-S was transcribed in the presence of
[-32P]-UTP (Amersham, 3000 Ci/mmol). Transcripts were
treated with DNAse I and purified by two rounds of phenol-
chloroform-isoamyl alcohol extraction, followed by two rounds
of chloroform-isoamyl alcohol extraction. The substrates
53Duplex#1 (L-SP6-ApaI  S-T7-SacI), 55Duplex#1 (L-T7-
SacI  S-SP6-Apa1), 55Duplex#2 (L-T7-NsiI  S-SP6-ApaI),
and 53Duplex#2 (L-SP6-ApaI  S-T7-NsiI) were generated
by annealing the short radiolabeled transcript with 10-fold
excess unlabeled long strand as described (Seybert et al.,
2000b).
The unwinding assay was performed in 20 l reac-
tions containing 400 M protein, 12 M substrate in 25
mM Tris buffer (pH 8.0), or HEPES buffer (ph 7.4) con-
taining 5 mM MgCl2, 2 mM DTT, 100 g/ml BSA, 10%
glycerol, 5 mM ATP, and 25 mM NaCl. Reactions were
incubated at 30°C for 1 h and stopped by adding 5 l of
5 loading buffer (5% SDS/15% Ficoll/100 mM EDTA/
0.25% bromphenol blue). Controls included in each as-
say were native (annealed) and denatured (heated at
95°C) substrate in the absence of helicase. The reaction
products were analyzed by native TBE–polyacrylamide
gel (4–20% gradient gel, Bio-Rad) electrophoresis and
autoradiography.
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